Antioxidant Vitaminas and Hypertrophy Adaptations to Resistance Training

August 1, 2021 updated by: María Martínez Ferrán, Universidad Europea de Madrid

Vitamins C and Vitamin E and Hypertrophy Adaptations to Resistance Traini

This investigations aims to investigate whether supplementation with antioxidant vitamins (vitamin C and vitamin E) can influence, enhancing or blocking, the hypertrophic adaptations caused by strength training in sedentary subjects.

Study Overview

Detailed Description

A randomized, double-blind, placebo-control controlled trial will be conducted. In a previous session volunteers will be interviewed to determine if they meet the inclusion criteria. Will be done two weeks of flushing out other types of supplementation and strenuous physical exercise, along with familiarization with the strength training program and performance tests to be carried out during the rehearsal. Subsequently, it will be a week without exercising to start with the experimental designs. From the start of the trial, participants should avoid physical exercise. strenuous outside the training protocol and if usual, they will only be able to perform one resistance training session per week. Participants should avoid ingesting of foods that contain high amounts of antioxidant compounds: more than two juices of fruits, more than four cups of coffee or tea. Juices with high antioxidant content should be avoided. Alcoholic beverages should also be avoided.

  • Group 1 (G1): Antioxidant vitamins (VitC (1000 mg) + VitE (235 mg)) + exercise
  • Group 2 (G2): Placebo + exercise A supplementation period of 12 weeks will be carried out. In each period, supplementation with antioxidant vitamins: VitC (1000 mg) + VitE (235 mg) or with placebo.

All participants will ingest the supplementation between 1-3 hours before training, the days of rest in the mornings.

All participants will perform a 12-week strength training protocol. The training session performed in the sharp design will be the first training session in chronic design. Being the baseline (E0) and post-exercise (E1) assessment performed in G1, G2 and G3 also the first evaluation corresponding to the chronic design.

In the middle of the supplementation period (week 6) and at the end, two new evaluations (week 12). Baseline evaluations will be performed prior to an exercise session of week 6 (E2) and at the last exercise session (E3) of the following parameters: performance physique, body composition, micronutrient analysis, muscle ultrasound. I also know conduct post-exercise physical performance assessments Figure 2.

The strength training protocol will be carried out 4 days a week at the facilities sports of the European University. The sessions will be planned by a professional from the Sciences of Physical Activity and Sports. Sessions will be tracked through a diary.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28011
        • Universidad Europea de Madrid

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Experience in strength training of at least one year

Exclusion Criteria:

  • Smokers
  • Antioxidant supplementation
  • Injuries or diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Supplementation group
Antioxidant vitamins (Vitamin C (1000 mg) + Vitamine E (235 mg))
1000 mg 235 mg
Other Names:
  • Ascorbic acid and tocopherol
PLACEBO_COMPARATOR: Placebo group
Placebo supplementation with the same aspect as supplementation
Placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DEXA
Time Frame: Week 0
Evaluation of muscle mass with dual energy X-ray absorptiometry
Week 0
DEXA
Time Frame: Week 10
Evaluation of muscle mass with dual energy X-ray absorptiometry
Week 10
Anthropometry
Time Frame: Week 0
Evaluation of muscle mass by a ISAK 1 level anthropometrist
Week 0
Anthropometry
Time Frame: Week 5
Evaluation of muscle mass by a ISAK 1 level anthropometrist
Week 5
Anthropometry
Time Frame: Week 10
Evaluation of muscle mass by a ISAK 1 level anthropometrist
Week 10
Bioimpedance
Time Frame: Week 0
Evaluation of muscle mass with an Inbody
Week 0
Bioimpedance
Time Frame: Week 5
Evaluation of muscle mass with an Inbody
Week 5
Bioimpedance
Time Frame: Week10
Evaluation of muscle mass with an Inbody
Week10
DOMS
Time Frame: Week 0
Delayed onset muscle soreness evaluated with visual analoguic scale (0 no pain- 10 maximal pain)
Week 0
DOMS
Time Frame: Week 5
Delayed onset muscle soreness evaluated with visual analoguic scale (0 no pain- 10 maximal pain)
Week 5
DOMS
Time Frame: Week 10
Delayed onset muscle soreness evaluated with visual analoguic scale (0 no pain- 10 maximal pain)
Week 10
Manual dinamometry
Time Frame: Week 0
Handgrip
Week 0
Manual dinamometry
Time Frame: Week 5
Handgrip
Week 5
Leg dinamometry
Time Frame: Week 0
Dinamometer
Week 0
Leg dinamometry
Time Frame: Week 5
Dinamometer
Week 5
Leg dinamometry
Time Frame: Week 10
Dinamometer
Week 10
RPE
Time Frame: Week 0
10-point scale (no exertion 0- maximal effort 10)
Week 0
RPE
Time Frame: Week 5
10-point scale (no exertion 0- maximal effort 10)
Week 5
RPE
Time Frame: Week 10
10-point scale (no exertion 0- maximal effort 10)
Week 10
1 RM
Time Frame: Week 0
Bench press and squats
Week 0
1 RM
Time Frame: Week 5
Bench press and squats
Week 5
1 RM
Time Frame: Week 10
Bench press and squats
Week 10
Parameters determined by ENCODER
Time Frame: Week 0
Bench press and squats
Week 0
Parameters determined by ENCODER
Time Frame: Week 5
Bench press and squats
Week 5
Parameters determined by ENCODER
Time Frame: Week 10
Bench press and squats
Week 10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2021

Primary Completion (ACTUAL)

April 15, 2021

Study Completion (ACTUAL)

June 30, 2021

Study Registration Dates

First Submitted

March 11, 2021

First Submitted That Met QC Criteria

March 30, 2021

First Posted (ACTUAL)

April 2, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 3, 2021

Last Update Submitted That Met QC Criteria

August 1, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertrophy

Clinical Trials on Placebo

3
Subscribe